Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. - Wikidata - wikimedia - TriplyDB

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.

http://www.wikidata.org/entity/Q34413225

about

Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL Principles of antibody-mediated TNF receptor activation Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma Crystal Structure of Human TWEAK in Complex with the Fab Fragment of a Neutralizing Antibody Reveals Insights into Receptor Binding Tumor bioengineering using a transglutaminase crosslinked hydrogel Identification of the sAPRIL binding peptide and its growth inhibition effects in the colorectal cancer cells Selective APRIL blockade delays systemic lupus erythematosus in mouse.Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas.Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications.APRIL is overexpressed in cancer: link with tumor progression Selective regulation of axonal growth from developing hippocampal neurons by tumor necrosis factor superfamily member APRIL APRIL mediates peritoneal B-1 cell homeostasis.Intrarenal production of B-cell survival factors in human lupus nephritis.APRIL induces tumorigenesis and metastasis of colorectal cancer cells via activation of the PI3K/Akt pathway Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID)Decreased Circulating Levels of APRIL: Questioning Its Role in Diabetes.Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation.Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE).The TNF family member APRIL promotes colorectal tumorigenesis An APRIL to remember: novel TNF ligands as therapeutic targets.Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey.Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa.Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell.APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment.APRIL stimulates NF-κB-mediated HoxC4 induction for AID expression in mouse B cells.Manipulating B cell homeostasis: a key component in the advancement of targeted strategies A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus.The BLyS family: toward a molecular understanding of B cell homeostasis.Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study.Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts.Synovial tissues concentrate secreted APRIL.The long-term survival of plasma cells.Roles for BLyS family members in meeting the distinct homeostatic demands of innate and adaptive B cells.Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus.Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma.Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2.Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases.

P2860

Q24681342-2833174A-28DA-4327-BEB6-4E0DD9DA1E4E Q26796270-8548B81A-0F5A-4C0E-B48D-6215A47C8D5F Q27001749-2F590591-61F0-458D-9762-9B2A93FA17AC Q27678102-836786B8-C89E-428A-A5AD-F0DF2C1E0405 Q28542066-AA0E17F3-3BFB-4CEA-AD15-C18626904E87 Q28545214-6ADEAEA6-E42D-44A0-83C2-51DBE7BAFCE6 Q31049002-9A5449A3-34CB-4702-8827-54AC5671A053 Q33325701-5CDD04C3-915B-4890-A95A-42804F06F767 Q33386608-214F7A4E-1629-4714-8278-E8448B6467DD Q33418752-BBEECD96-9F5C-4A24-B1CC-A59335D28BC2 Q33559757-19B61271-5179-428A-B335-A0BE23B85C86 Q33758475-7A4A705E-6C78-42EA-9130-DEAB47619966 Q34141439-7CE1A7E8-C41B-4D63-B4B9-DC1D2FAC25F0 Q34576347-0B819B27-7698-4E8B-8228-89C2D3B5FE95 Q35781772-3AD8A259-1718-472F-86A6-9DEB656C88BA Q35808734-222DC375-6BF1-4CCF-9AB1-295352C4C34A Q36118295-2F2C0073-633B-467D-97BE-DC4752C0BAE6 Q36238843-04AC8B65-4BFE-46C0-9112-0A51C8FA0CE0 Q36271212-41582491-94BB-4C84-9366-E006C2CF54B7 Q36311159-AC9412C1-543B-49A8-82A6-69D689F4361A Q36394955-54432357-F2F1-441F-980A-76DF2C0DD6F4 Q36489766-E889BCC4-92C4-441C-BD8B-223180F38236 Q36530420-AA4BE1CF-2AD6-4EFB-B439-DC3B3688678C Q36749700-38398F5A-2177-405B-AAD5-2B07594EB1DC Q37004635-D117CFBE-128A-403E-B801-0740B67A44A0 Q37035836-FBDFC947-E262-460D-84F8-5E62A0D25E4B Q37045143-D14705A6-951F-4210-908B-C96C29F400E1 Q37177128-9A9BD6DB-5C79-4460-932A-6866E612BCCE Q37201980-EA7E082F-6208-436B-B590-1439C2D13D4D Q37328468-78FAED9B-4D9A-4A9A-BF95-62749527EA79 Q37335169-6108C045-503D-4DE6-8DAF-8F65C2AE19FD Q37400568-BC5F5E32-16FB-4B2D-87A1-3E9B195B1B9C Q37407676-2AEB6AC7-4BBB-4918-A944-FA3BBFD7848E Q37454022-3F65F154-CD78-49E5-947E-3373149367E7 Q37847223-24960474-B9FE-451E-BD8C-E811050DB958 Q38084919-525B4720-4ACC-4564-B9C5-ACEDA5DE4537 Q38187489-7174CED1-A13A-4B11-A180-B99DB5A4F4F8 Q38312824-C5A7B299-596F-4B01-9910-7994867D3B80 Q38659118-54D5D8E0-DE96-4C84-BF5F-54A7220ADFBC Q38755707-6302F2A3-3B9A-4BFD-8C99-27B986698FDB

P2860

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.

http://www.wikidata.org/entity/Q34413225

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.

@ast

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.

@en

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.

@nl

type

label

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.

@ast

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.

@en

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.

@nl

prefLabel

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.

@ast

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.

@en

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.

@nl

P1433

Q34413225-2D269AE5-0433-4D20-864A-B28E6AF9D229

P1476

Q34413225-80B25F35-DB74-4FB6-B4AF-67B6380D20FC

P2093

Q34413225-1049CCC9-703F-401E-A9FE-C314A06277D2

Q34413225-3C1D187D-4DFE-4299-93F3-BC154110A7F8

Q34413225-412904D0-97CA-4115-9B1E-82EFF8494AC8

Q34413225-4B6A0E90-C6EF-4B8A-BECF-4746E44C3DBB

Q34413225-9DDFA53A-1F80-42B5-AA7B-7C4BC90BE338

Q34413225-BA090989-BA2C-4816-A78D-DB6399C36DF9

Q34413225-F19AE8FB-2C7C-4C4B-B215-2BF4C2B4E348

P2888

Q34413225-511555C5-C1D3-4CD8-A9A5-398C70ACD2FF

P304

Q34413225-E291389D-E23B-4A9E-A39F-0CA01667DDEE

P31

Q34413225-F18EBB75-CCD0-4FFC-AF5A-86E7DD133647

P356

Q34413225-B1FE0D84-BC8F-448A-8C4B-D871367143E2

P433

Q34413225-E22230E6-D9B8-4F0A-BB09-0CF1746E7743

P478

Q34413225-40C09247-7488-434E-BD3C-C44ABC39CD83

P50

Q34413225-A2668686-CE61-4A54-85BF-872E4AF30481

P577

Q34413225-F2269870-DD3F-415B-8FB9-F52DA56B0042

P5875

Q34413225-2B33F890-3A23-4CC7-B836-C5E329816178

P698

Q34413225-D10245DB-30C4-46EA-AA53-6C416053E6A1

P356

P1433

Cell Death & Differentiation

P1476

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation

@en

P2093

Hahne M

http://www.w3.org/2001/XMLSchema#string

Hardenberg G

http://www.w3.org/2001/XMLSchema#string

Hendriks J

http://www.w3.org/2001/XMLSchema#string

Medema JP

http://www.w3.org/2001/XMLSchema#string

Pals ST

http://www.w3.org/2001/XMLSchema#string

Planelles L

http://www.w3.org/2001/XMLSchema#string

de Jong-Odding J

http://www.w3.org/2001/XMLSchema#string

P2888

P304

637-648

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.CDD.4401647

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Marcel Spaargaren

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7891951

http://www.w3.org/2001/XMLSchema#string

P698

15846369

http://www.w3.org/2001/XMLSchema#string